Potential clinical application of antioncogene ribozymes for human lung cancer

Clinical Lung Cancer

Volumn 2, Issue 3, 2001, Pages 220-226

  Tong, A W ^a   Zhang, Y A ^a   Cunningham, C ^a   Maples, P ^a   Nemunaitis, J ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenoviral vector; Gene therapy; Lung cancer; Oncogene; Ras mutations; Ribozyme

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GENE PRODUCT; GUANINE; MULTIDRUG RESISTANCE PROTEIN; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; RIBOZYME; RNA; THYMINE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASE PAIRING; CANCER CELL; CANCER INHIBITION; CANCER REGRESSION; CATALYSIS; CELL SPECIFICITY; CODON; CONTROLLED STUDY; EFFECTOR CELL; ENZYME ACTIVITY; GENE INACTIVATION; GENE MUTATION; GENE TARGETING; GENE THERAPY; GENETIC COMPLEMENTATION; GENETIC DISORDER; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MOLECULE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NUDE MOUSE; ONCOGENE; ONCOGENE K RAS; ONCOGENE RAS; PATHOPHYSIOLOGY; RNA BINDING; RNA CLEAVAGE; RNA SEQUENCE; RNA TRANSCRIPTION; STOICHIOMETRY; TRANSGENE; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

EID: 0034460980     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/clc.2001.n.007     Document Type: Article

References (65)

1. A small catalytic oligoribonucleotide
2. Self-splicing of group I introns
3. Therapeutic applications of ribozymes
4. Simple RNA enzymes with new and highly specific endoribonuclease activities
5. Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene
6. Ribozymes as tools for therapeutic target validation in arthritis
7. Multi-ribozyme targeting of human alpha-globin gene expression
8. Ribozymes in treatment of inherited retinal disease
9. Sequence requirements of the hammerhead RNA self-cleavage reaction
10. Small efficient hammerhead ribozymes
11. Ribozyme-mediated reversal of human pancreatic carcinoma phenotype
12. mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines
13. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA
14. Anti-K-ras ribozyme induces growth inhibition and increased chemosensitivity in human colon cancer cells
15. Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma
16. Inhibition of cell proliferation in HCC-9204 hepatoma cells by a c-myc specific ribozyme
17. ERbB-2 expression is rate-limiting for epidermal growth factor-mediated stimulation of ovarian cancer cell proliferation
18. Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells
19. Application of ribozymes to cancer gene therapy
20. Multi-unit ribozyme-mediated cleavage of bcr-abl mRNA in myeloid leukemias
21. Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors
22. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells
23. Molecular mechanisms of action of antisense drugs
24. The inhibitory effect of adenovirus-mediated p16INK4a gene transfer on the proliferation of lung cancer cell line
25. Molecular themes in oncogenesis
26. Expression patterns of immediate early transcription factors in human non-small cell lung cancer
27. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer
28. Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung
29. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung
30. The molecular biology of lung cancer pathogenesis
31. Reversible inhibition of IL-8 receptor B mRNA expression and proliferation in non-small cell lung cancer by antisense oligonucleotides
32. Transfection of anti-sense complementary DNA of human epidermal-growth-factor receptor attenuates the proliferation of human non-small-cell-lung-cancer cells
33. Inhibition of lung cancer proliferation by antisense cyclin D
34. Ras genes
35. Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA - In vitro and in vivo studies
36. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis
37. Creation of human tumour cells with defined genetic elements
38. Essential role for oncogenic Ras in tumour maintenance
39. Signal transduction as target of gene therapy
40. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation
41. Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion
42. Non-Ras targets of farnesyltransferase inhibitors: Focus on Rho
43. Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer
44. Anti-K-ras ribozyme adenoviral vector for gene therapy of non-small cell lung cancer
45. The use of ribozymes for gene therapy of lung cancer
46. H-ras ribozyme-mediated alteration of the human melanoma phenotype
47. Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme
48. Intracellular metabolism of a 2′-O-methyl-stabilized ribozyme after uptake by DOTAP transfection or asfree ribozyme. A study by capillary electrophoresis
49. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct
50. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype
51. Therapeutic efficacy of an adenovirus-mediated anti-H-ras ribozyme in experimental bladder cancer
52. Gene therapy for lung disease: Hype or hope?
53. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
54. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer
55. Safety evaluation of Ad5CMV-p53 in vitro and in vivo
56. Role of early genes in pathogenesis of adenovirus pneumonia
57. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice
58. Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts
59. p53 tumor suppressor gene therapy for cancer
60. Novel approaches to locally advanced unresectable non-small cell lung cancer
61. CT-guided intratumoral gene therapy in non-small-cell lung cancer
62. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer
63. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer
64. Gene therapy. The best of times, the worst of times
65. IL-2 gene therapy of advanced lung cancer patients